RNC Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
RNC Capital Management's NVS Position: Q4 2025 in Review
RNC Capital Management increased its Novartis (NVS) stake by 3.7% in Q4 2025, buying an estimated $21.2K and bringing the position to 4,598 shares worth $634K. The position accounts for 0.03% of the portfolio, ranked #122.
RNC Capital Management first reported a position in NVS in Q2 2016 and has held it in 20 quarters since. 1,508 funds tracked by Wall St. Rank hold NVS as of Q4 2025.
- RNC Capital Management held 4,598 shares of Novartis worth $634K as of Q4 2025.
- RNC Capital Management bought 162 Novartis shares in Q4 2025, an estimated $21.2K.
- Novartis made up 0.03% of RNC Capital Management's portfolio in Q4 2025, its #122 holding.
- RNC Capital Management first reported a position in Novartis in Q2 2016 and has held it in 20 quarters since.
- 1,508 funds tracked by Wall St. Rank held Novartis as of Q4 2025.
Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.